Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
A synthetic targeted RNA demethylation system based on CRISPR-Cas13b inhibits bladder cancer progression.
Clin Transl Med. 2022 Feb;12(2):e734. doi: 10.1002/ctm2.734.
Clin Transl Med. 2022.
PMID: 35220684
Free PMC article.
No abstract available.
A CRISPR/dCasX-mediated transcriptional programming system for inhibiting the progression of bladder cancer cells by repressing c-MYC or activating TP53.
Cao C, Yao L, Li A, Zhang Q, Zhang Z, Wang X, Gan Y, Liu Y, Zhang Q.
Cao C, et al.
Clin Transl Med. 2021 Sep;11(9):e537. doi: 10.1002/ctm2.537.
Clin Transl Med. 2021.
PMID: 34586743
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite